Latest news with #Acclinate
Associated Press
a day ago
- Health
- Associated Press
Brunch, Bold Conversations, and Better Health: Michigan Series Spotlights Myasthenia Gravis
Detroit, MI June 13, 2025 --( )-- Imagine brunch with bold conversation, powerful stories, and an immersive health experience- all designed to uplift and inform communities often overlooked in healthcare conversations. That's the idea behind Brunch & Learn: Myasthenia Gravis Edition, a new four-city Michigan event series hosted by Acclinate's NOWINCLUDED platform. This free series invites guests to enjoy good food while learning about myasthenia graves (MG) - a rare neuromuscular disease that impacts women and is frequently misdiagnosed in Black and Brown communities through personal stories, interactive activities, and expert insights, guests will walk away with more than a meal- they'll gain knowledge, community and purpose. View Event Video And Photos Here Upcoming Dates and Locations June 14 - Detroit @ Garden Theater, 3929 Woodward Avenue What Makes This Brunch Different? Live storytelling from MG warriors and medical experts Bold Conversations that spark real, relatable dialogue Immersive VR Experience simulating life with MG Free Giveaways - Free Brunch Wellness sessions and community-centered health education 'This is more than awareness-it's about creating safe, engaging spaces for communities of color to be seen, heard, and informed,' says Shayla Wilson, Head of Community at Acclinate. We're meeting people where they are and making health education something they'll actually want to show up for.' Ready to Brunch? Reserve your spot and enjoy the full experience now Contact Information: Acclinate Joanna Sheppard 205-229-8162 Contact via Email Read the full story here: Brunch, Bold Conversations, and Better Health: Michigan Series Spotlights Myasthenia Gravis Press Release Distributed by
Yahoo
20-02-2025
- Health
- Yahoo
Birmingham startup using clinical trials to improve medical care for minorities
BIRMINGHAM, Ala. (WIAT) — Birmingham startup Acclinate is conducting medical trials focused on minorities to better address the medical needs of their communities. Tiffany Whitlow and Del Smith founded Acclinate in 2020 and now have over 50 employees in a footprint that includes Birmingham, Huntsville, and Washington, D.C. Time running out to save a slice of civil rights history in the Texas Panhandle For Whitlow, starting Acclinate was personal. 'My son was diagnosed with asthma,' said Whitlow. 'He was given an albuterol inhaler. I had no idea at the time albuterol is 47% less effective in African-Americans and 67% less effective in Puerto Ricans.' The 2020 census reported that minorities make up 40% of the U.S. population, but only participate in 2% of clinical trials. Because they are not included in the research, the medication is less effective for some groups. Skepticism for trials is motivated by events like the Tuskegee Syphilis Study, which studied untreated syphilis in African-American men without their consent, even after treatment became widely available. The study ended in 1972. Another event motivating skepticism is the harvesting and study of Henrietta Lacks' cervical cells in 1951, which were used without her knowledge or consent. 'You can't just shy over that,' said Whitlow. 'People want to know that you're aware.' With more than 120,000 people participating in Acclinate's trials, their influence is growing. Whitlow plans to increase that number to 500,000 in the coming months. For more information, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
